The receipts

Research library.

Every peer-reviewed paper cited anywhere on PepCue, in one index. Each record is resolved against the live PubMed entry, and the study-type label comes from PubMed's own classification rather than our opinion of the paper.

274
indexed papers
88
randomized trials
16
reviews & meta-analyses
196
human studies
43
preclinical only
What this index is, and is not
These are citation records: title, journal, date, authors, identifiers, and the study type PubMed assigns. We do not reproduce abstracts, and a paper appearing here is not an endorsement of the compound it discusses. A randomized trial that found no effect is indexed exactly the same way as one that did.

274 papers

Systematic review / meta-analysisHuman2026
Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta-Analysis of Randomised Controlled Trials

Endocrinology, diabetes & metabolism · cited on Mazdutide

Systematic review / meta-analysisHuman2026
Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

Diabetes, obesity & metabolism

Systematic review / meta-analysisHuman2026
Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition : A Systematic Review

Annals of internal medicine

Systematic review / meta-analysisHuman2026
Effect of GLP-1 receptor agonists at doses for obesity management on muscle health: systematic review and meta-analysis of randomized controlled trials (RCTs)

International journal of obesity (2005)

Systematic review / meta-analysisHuman2025
Glutathione as a skin-lightening agent and in melasma: a systematic review

International journal of dermatology · cited on Glutathione

Systematic review / meta-analysisHuman2023
Cerebrolysin for acute ischaemic stroke

The Cochrane database of systematic reviews · cited on Cerebrolysin

Systematic review / meta-analysisHuman2021
Re-Analyzing Phase III Bremelanotide Trials for "Hypoactive Sexual Desire Disorder" in Women

Journal of sex research · cited on PT-141

Systematic review / meta-analysisHuman2019
The clinical effect of glutathione on skin color and other related skin conditions: A systematic review

Journal of cosmetic dermatology · cited on Glutathione

Systematic review / meta-analysisHuman2019
Cerebrolysin for vascular dementia

The Cochrane database of systematic reviews · cited on Cerebrolysin

Systematic review / meta-analysisHuman2018
Cancer Incidence in Patients With Acromegaly: A Cohort Study and Meta-Analysis of the Literature

The Journal of clinical endocrinology and metabolism

Systematic review / meta-analysisHuman2016
The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials

BMC infectious diseases · cited on Thymosin α-1

Systematic review / meta-analysisHuman2010
Placebo interventions for all clinical conditions

The Cochrane database of systematic reviews

Systematic review / meta-analysisHuman2010
Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation

Health technology assessment (Winchester, England) · cited on Human Growth Hormone

Systematic review / meta-analysisHuman2009
Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention

BMC medical research methodology

Systematic review / meta-analysisHuman2007
Systematic review: the safety and efficacy of growth hormone in the healthy elderly

Annals of internal medicine · cited on Human Growth Hormone

Systematic review / meta-analysisHuman1995
The effect of human chorionic gonadotropin (HCG) in the treatment of obesity by means of the Simeons therapy: a criteria-based meta-analysis

British journal of clinical pharmacology · cited on HCG

Randomized controlled trialHuman2026
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial

Lancet (London, England) · cited on Orforglipron

Randomized controlled trialHuman2026
Cardiac safety of chronic inhibition of the myostatin-activin pathway with bimagrumab in healthy older adults

The Journal of clinical endocrinology and metabolism · cited on ACE-031

Randomized controlled trialHuman2026
Mazdutide 9 mg in Chinese adults with a body mass index ≥30 kg/m(2) but without diabetes: A phase 2 randomized controlled trial

Med (New York, N.Y.) · cited on Mazdutide

Randomized controlled trialHuman2026
Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, phase 3a trial

The lancet. Diabetes & endocrinology · cited on CagriSema

Randomized controlled trialHuman2026
Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial

Nature medicine · cited on Orforglipron

Randomized controlled trialHuman2026
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial

Lancet (London, England)

Randomized controlled trialHuman2026
Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes: The ACHIEVE-5 Randomized Clinical Trial

JAMA · cited on Orforglipron

Randomized controlled trialHuman2026
Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study

The lancet. Diabetes & endocrinology · cited on Cagrilintide

Randomized controlled trialHuman2026
Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial

Nature medicine · cited on Survodutide

Randomized controlled trialHuman2026
Survodutide Once Weekly for the Treatment of Adults with Obesity

The New England journal of medicine · cited on Survodutide

Randomized controlled trialHuman2025
End-organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2)

European journal of heart failure · cited on B7-33

Randomized controlled trialHuman2025
Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study

Stroke · cited on Cerebrolysin

Randomized controlled trialHuman2025
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis

The New England journal of medicine · cited on Semaglutide

Randomized controlled trialHuman2025
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight

The New England journal of medicine · cited on Mazdutide

Randomized controlled trialHuman2025
Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

The New England journal of medicine · cited on CagriSema

Randomized controlled trialHuman2025
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity

The New England journal of medicine · cited on Cagrilintide, CagriSema

Randomized controlled trialHuman2025
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes

The New England journal of medicine · cited on Orforglipron

Randomized controlled trialHuman2025
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial

The lancet. Diabetes & endocrinology

Randomized controlled trialHuman2025
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment

The New England journal of medicine · cited on Orforglipron

Randomized controlled trialHuman2024
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial

JAMA

Randomized controlled trialHuman2024
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial

The lancet. Diabetes & endocrinology · cited on Survodutide

Randomized controlled trialHuman2024
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity

The New England journal of medicine · cited on Tirzepatide

Randomized controlled trialHuman2023
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

The Lancet. Respiratory medicine · cited on VIP

Randomized controlled trialHuman2023
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

The New England journal of medicine · cited on Orforglipron

Randomized controlled trialHuman2023
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial

The New England journal of medicine · cited on Retatrutide

Randomized controlled trialHuman2023
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study

Lancet (London, England) · cited on Orforglipron

Randomized controlled trialHuman2023
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

Lancet (London, England) · cited on Retatrutide

Randomized controlled trialHuman2023
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

The New England journal of medicine · cited on Semaglutide

Randomized controlled trialHuman2023
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity

Nature communications · cited on Mazdutide

Randomized controlled trialHuman2022
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

Diabetes, obesity & metabolism

Randomized controlled trialHuman2022
Tirzepatide Once Weekly for the Treatment of Obesity

The New England journal of medicine · cited on Tirzepatide

Randomized controlled trialHuman2022
0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial

International journal of molecular sciences · cited on Thymosin β-4

Randomized controlled trialHuman2021
Once-Weekly Semaglutide in Adults with Overweight or Obesity

The New England journal of medicine · cited on Semaglutide

Randomized controlled trialHuman2021
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial

JAMA

Randomized controlled trialHuman2021
Combination of topical and oral glutathione as a skin-whitening agent: a double-blind randomized controlled clinical trial

International journal of dermatology · cited on Glutathione

Randomized controlled trialHuman2021
Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined

The New England journal of medicine

Randomized controlled trialHuman2021
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

The New England journal of medicine · cited on Tirzepatide

Randomized controlled trialHuman2021
Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder

The New England journal of medicine · cited on Oxytocin

Randomized controlled trialHuman2021
Evaluation of LL-37 in healing of hard-to-heal venous leg ulcers: A multicentric prospective randomized placebo-controlled clinical trial

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · cited on LL-37

Randomized controlled trialHuman2020
Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial

Molecular psychiatry · cited on Oxytocin

Randomized controlled trialHuman2020
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial

The Journal of clinical endocrinology and metabolism · cited on Human Growth Hormone

Randomized controlled trialHuman2019
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials

Obstetrics and gynecology · cited on PT-141

Randomized controlled trialHuman2019
Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial

The lancet. HIV · cited on Tesamorelin

Randomized controlled trialHuman2017
Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial

Muscle & nerve · cited on ACE-031

Index rebuilt 2026-09-23 from NCBI E-utilities.

Keep reading
How we grade evidenceThe evidence boardAll compoundsGlossary
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds